NEXHALER
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77658464 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Maribeth Day Case |
| Attorney Name | Diane K. Fry |
| Attorney Docket Number | APP/NEXHALER |
| Law Office Assigned | L40 |
| Employee Name | WILKE, JOHN |
Timeline
| 2009-01-28 | Application Filed |
| 2009-11-17 | Published for Opposition |
| 2011-02-04 | Location: INTENT TO USE SECTION |
| 2011-07-18 | Abandon |
| 2011-07-19 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Address | Glaxo Wellcome House Berkeley Avenue Greenford, Middles GB UB60NN |
| Legal Entity Type | Corporation |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Medical and surgical apparatus and instruments, namely, inhalers sold empty, and structural parts and fittings therefor |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2009-01-31 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-02-02 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF PSEUDO MARK MAILED | 2009-02-03 | 3 MPMK O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2009-04-06 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2009-04-13 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2009-04-13 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2009-04-13 | 7 GNRN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2009-09-10 | 8 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2009-09-10 | 9 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-09-11 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-09-11 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2009-09-11 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2009-09-28 | 13 CNSA P: |
| ASSIGNED TO LIE | 2009-10-14 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2009-10-14 | 15 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2009-11-17 | 16 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2009-11-17 | 17 NPUB E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-11-18 | 18 TCCA I:Incoming Correspondence |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2010-02-09 | 19 NOAM O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2010-05-12 | 20 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2010-07-08 | 21 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2010-07-08 | 22 EXT1 S: |
| EXTENSION 1 GRANTED | 2010-07-08 | 23 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-07-10 | 24 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2011-01-13 | 25 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2011-02-04 | 26 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2011-01-13 | 27 EXT2 S: |
| EXTENSION 2 GRANTED | 2011-02-04 | 28 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2011-02-05 | 29 EXRA E:E-Mail |
| TEAS EXPRESS ABANDONMENT RECEIVED | 2011-07-18 | 30 EXAR I:Incoming Correspondence |
| ABANDONMENT - AFTER PUBLICATION | 2011-07-19 | 31 ABN5 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | 2011-07-19 | 32 MAB5 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NEXHALER 77824415 not registered Dead/Abandoned |
Glaxo Group Limited 2009-09-11 |
 NEXHALER 77658464 not registered Dead/Abandoned |
Glaxo Group Limited 2009-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 